Загрузка видео...

Не удалось загрузить видео

На главную

🔴 Ikerbasque Research Fellows call is now open! We offer 20 positions for experienced postdoctoral researchers 📅 Deadline: March 15 For further information, please visit #science #research #ApplyNow

Ikerbasque's profile picture

Ikerbasque

8,607 subscribers

15,062 просмотров • 2 лет назад •via X (Twitter)

Наука и технологииОбразование#science#research#ApplyNow
LIVE

Anya Rossi• Live Now

Private livecam show

Комментарии: 0

Нет доступных комментариев

Здесь появятся комментарии из оригинального поста

Похожие видео

📢Our Research Development Fellowship application is now open! We are funding early-career researchers in Africa: 💷 Up to £47,000 funding 🥼Work with experts in world leading research institutions 💡Join over 60+ fellows and 400+ alumni Learn more👉🏾
0:10

📢Our Research Development Fellowship application is now open! We are funding early-career researchers in Africa: 💷 Up to £47,000 funding 🥼Work with experts in world leading research institutions 💡Join over 60+ fellows and 400+ alumni Learn more👉🏾

Africa Research Excellence Fund

50,673 просмотров • 3 лет назад

We are excited to see researchers and students continue pushing open-source robotics forward with Open Ant 🐜 The project uses XC430 and XM430 actuators to bring agile locomotion to life. Proud to support innovation in robotics education, research, and biomimetic systems worldwide. Explore the Openmind Research Institute Github for more information -
0:13

We are excited to see researchers and students continue pushing open-source robotics forward with Open Ant 🐜 The project uses XC430 and XM430 actuators to bring agile locomotion to life. Proud to support innovation in robotics education, research, and biomimetic systems worldwide. Explore the Openmind Research Institute Github for more information -

ROBOTIS AMERICA

14,478 просмотров • 2 месяцев назад

📣 Calling all early-career researchers! Applications are now OPEN for the CIFAR Azrieli Foundation #GlobalScholars program, a unique opportunity to transform your research and accelerate your career. Apply by Nov. 20:
0:15

📣 Calling all early-career researchers! Applications are now OPEN for the CIFAR Azrieli Foundation #GlobalScholars program, a unique opportunity to transform your research and accelerate your career. Apply by Nov. 20:

CIFAR

16,627 просмотров • 1 год назад

We're delighted to announce the next cycle of recruitment for our 125th Anniversary Fellows and Chairs is now open! If you are an academic with a strong portfolio of global-leading research, we want to hear from you. Check out our vacancies and apply now:
0:20

We're delighted to announce the next cycle of recruitment for our 125th Anniversary Fellows and Chairs is now open! If you are an academic with a strong portfolio of global-leading research, we want to hear from you. Check out our vacancies and apply now:

Uni of Birmingham

42,955 просмотров • 1 год назад

Our internship program at Polymathic is open for opportunities from now through fall 2025! I believe our program provides an opportunity to work alongside some of the best researchers and engineering experts in the world — exploring the unknown of building foundation models for science, together. These are full-time and paid positions in the Big Apple! Interested? 👇 Deadline Nov 5!
0:15

Our internship program at Polymathic is open for opportunities from now through fall 2025! I believe our program provides an opportunity to work alongside some of the best researchers and engineering experts in the world — exploring the unknown of building foundation models for science, together. These are full-time and paid positions in the Big Apple! Interested? 👇 Deadline Nov 5!

Shirley Ho

58,680 просмотров • 1 год назад

Calling all #STEM leaders! Applications for graduate studies at #KAUST are now open. This is your opportunity to advance your academic journey in a world-class research environment. Visit our website and apply now. #ApplyKAUST
0:15

Calling all #STEM leaders! Applications for graduate studies at #KAUST are now open. This is your opportunity to advance your academic journey in a world-class research environment. Visit our website and apply now. #ApplyKAUST

KAUST

698,106 просмотров • 2 лет назад

It's here! 🎉 Environmental Research 2023, IOP Publishing's virtual event series, will be taking place over an entire month starting in October. The event is free and open to anyone internationally! Visit our conference webpage for more information 👉
0:11

It's here! 🎉 Environmental Research 2023, IOP Publishing's virtual event series, will be taking place over an entire month starting in October. The event is free and open to anyone internationally! Visit our conference webpage for more information 👉

IOP Publishing

11,809 просмотров • 3 лет назад

Introducing gGNS: Unlocking $GNS as Trading Collateral. The vault is now open for deposits. Trading will be enabled on March 15. Visit the gGNS vault at ➡️
0:13

Introducing gGNS: Unlocking $GNS as Trading Collateral. The vault is now open for deposits. Trading will be enabled on March 15. Visit the gGNS vault at ➡️

gTrade | Gains Network 🍏

12,250 просмотров • 1 год назад

Today is #WomenInScienceDay and we want to give a big shout out to all the amazing women who power our research (and to all the girls looking for a future career in science)! Drop a like to show these incredible researchers your appreciation! 👇 ❤️ #WomenInScience 👩‍🔬🔬
0:12

Today is #WomenInScienceDay and we want to give a big shout out to all the amazing women who power our research (and to all the girls looking for a future career in science)! Drop a like to show these incredible researchers your appreciation! 👇 ❤️ #WomenInScience 👩‍🔬🔬

Blood Cancer UK

14,736 просмотров • 3 лет назад

The #EAPCI26 Summit is a gathering of leaders and rising talents in interventional cardiology and related specialties. The call for science is now open! Submit your work and be among the first to influence practice. 📅 Abstracts - 16 October | Clinical cases - 23 October #EAPCI EAPCIPresident
0:14

The #EAPCI26 Summit is a gathering of leaders and rising talents in interventional cardiology and related specialties. The call for science is now open! Submit your work and be among the first to influence practice. 📅 Abstracts - 16 October | Clinical cases - 23 October #EAPCI EAPCIPresident

European Society of Cardiology

21,356 просмотров • 11 месяцев назад

I believe solving robotics = 90% engineering + 10% research vision. Project GR00T is NVIDIA's moonshot initiative to build physical AGI for humanoid robots. The GEAR Lab is assembling a crack team right now. Join us! Openings: - Sr. Research Engineer, Robotics Systems - Sr. RE, Reinforcement Learning - Sr. RE, Foundation Model Training Infrastructure - Sr. RE, Simulation - Sr. RE, ML Data Pipelines - Research Scientist - Research Intern (both part-time and summer full-time in 2025) For the Sr. positions, we strongly prefer candidates with many years of engineering experience at robotics/autonomous driving companies, or MLOps/large-scale AI teams at big techs. For interns, we welcome ace robotics hackers anywhere! Show me your past works. Job links in the thread. Apply today! Your resumes will be my best Christmas gifts:
0:16

I believe solving robotics = 90% engineering + 10% research vision. Project GR00T is NVIDIA's moonshot initiative to build physical AGI for humanoid robots. The GEAR Lab is assembling a crack team right now. Join us! Openings: - Sr. Research Engineer, Robotics Systems - Sr. RE, Reinforcement Learning - Sr. RE, Foundation Model Training Infrastructure - Sr. RE, Simulation - Sr. RE, ML Data Pipelines - Research Scientist - Research Intern (both part-time and summer full-time in 2025) For the Sr. positions, we strongly prefer candidates with many years of engineering experience at robotics/autonomous driving companies, or MLOps/large-scale AI teams at big techs. For interns, we welcome ace robotics hackers anywhere! Show me your past works. Job links in the thread. Apply today! Your resumes will be my best Christmas gifts:

Jim Fan

103,177 просмотров • 1 год назад

⭐ EXCITING ANNOUNCEMENT⭐ is back next year! Hosted by , the creator of Vue CALL FOR PAPERS IS OPEN! (Closing Jan 1, so be quick) Submit your papers to the largest Vue conf in the US now here- 📍Tampa, FL 📅 May 13-15
0:20

⭐ EXCITING ANNOUNCEMENT⭐ is back next year! Hosted by , the creator of Vue CALL FOR PAPERS IS OPEN! (Closing Jan 1, so be quick) Submit your papers to the largest Vue conf in the US now here- 📍Tampa, FL 📅 May 13-15

Vueconf.US

30,342 просмотров • 1 год назад

[MESSAGE FROM THE CLERGY] We wish to inform you that the countdown is on for RITE HERE RITE NOW. Only 3 weeks to go until you can celebrate the GHOST live spectacle in cinemas around the world. Haunting cinemas worldwide on June 20, 21, 22, and 23. Visit for more information. #RiteHereRiteNow
0:20

[MESSAGE FROM THE CLERGY] We wish to inform you that the countdown is on for RITE HERE RITE NOW. Only 3 weeks to go until you can celebrate the GHOST live spectacle in cinemas around the world. Haunting cinemas worldwide on June 20, 21, 22, and 23. Visit for more information. #RiteHereRiteNow

Papa V Perpetua

110,054 просмотров • 2 лет назад

Agentic traces contain perfect information about an agent’s behavior with every plan, action, and retry. But that information gets lost in a sea of JSON. So we built AgentPrism: open source React components that turn traces into visual diagrams for debugging AI agents. You can plug in your OpenTelemetry data and see your agent’s process unfold: messages, tool calls, retries. Quotient AI automatically monitors, analyzes, and improves AI agents. Being able to review traces quickly is paramount for their research, and for their customers. “Dealing with agent traces was one of the biggest frustrations for our researchers and a huge time sink. All of that has gone away since adding AgentPrism, and we’re excited to bring that functionality to our users.” — Julia Neagu
0:12

Agentic traces contain perfect information about an agent’s behavior with every plan, action, and retry. But that information gets lost in a sea of JSON. So we built AgentPrism: open source React components that turn traces into visual diagrams for debugging AI agents. You can plug in your OpenTelemetry data and see your agent’s process unfold: messages, tool calls, retries. Quotient AI automatically monitors, analyzes, and improves AI agents. Being able to review traces quickly is paramount for their research, and for their customers. “Dealing with agent traces was one of the biggest frustrations for our researchers and a huge time sink. All of that has gone away since adding AgentPrism, and we’re excited to bring that functionality to our users.” — Julia Neagu

Evil Martians

101,372 просмотров • 10 месяцев назад

I just built my own wiki generator plugin for my agents. My agents can now generate wikis for anything I ask. One of my favorite wikis is called PaperWiki. This is a great example of what Andrej Karpathy describes. It uses obsidian vaults to organize papers, retrieve LLM-generated summaries, diagrams, and other advanced views for paper exploration. When Obsidian UI is not enough, I use my own artifact generator inside my agent orchestrator (see clip for example). This allows my agents to build any kind of view or exploration feature that I need. The papers are all curated with automations and several rules/patterns I have manually built over the years. On the surface, this looks basic. But behind the scenes, there are advanced search capabilities, connections, metadata, derived data, and other interesting bits of information that are extremely useful for my research agents. This is mostly built for agents. The artifact preview is just a high-level way to validate and quickly assess the quality of the wiki, suggest improvements, and it's also great for research. I use tobi lutke's qmd for all search capabilities. Everything is markdown. The summaries and even the diagrams. The wiki updates on its own based on several automations I have optimized over the past couple of weeks. The wiki grows and self-improves based on several requirements important for my research use cases. This is as personalized as it gets. There is nothing like it out there. And I use my research expertise to continue improving it over time. This is a vanilla wiki. There are so many things I want to build on top of this. Different aggregations, views, artifacts, etc. All to help automate more of my research work and accelerate productivity. I think the biggest leverage here is how powerful this could be for discovery and experimentation. One of my goals is to use it to find deeper connections and insights that would otherwise elude the top human researchers and use those to generate interesting new hypotheses and research experiments. That way, my agents can use autoresearch to explore research ideas at the frontier. Stay tuned for more.
0:16

I just built my own wiki generator plugin for my agents. My agents can now generate wikis for anything I ask. One of my favorite wikis is called PaperWiki. This is a great example of what Andrej Karpathy describes. It uses obsidian vaults to organize papers, retrieve LLM-generated summaries, diagrams, and other advanced views for paper exploration. When Obsidian UI is not enough, I use my own artifact generator inside my agent orchestrator (see clip for example). This allows my agents to build any kind of view or exploration feature that I need. The papers are all curated with automations and several rules/patterns I have manually built over the years. On the surface, this looks basic. But behind the scenes, there are advanced search capabilities, connections, metadata, derived data, and other interesting bits of information that are extremely useful for my research agents. This is mostly built for agents. The artifact preview is just a high-level way to validate and quickly assess the quality of the wiki, suggest improvements, and it's also great for research. I use tobi lutke's qmd for all search capabilities. Everything is markdown. The summaries and even the diagrams. The wiki updates on its own based on several automations I have optimized over the past couple of weeks. The wiki grows and self-improves based on several requirements important for my research use cases. This is as personalized as it gets. There is nothing like it out there. And I use my research expertise to continue improving it over time. This is a vanilla wiki. There are so many things I want to build on top of this. Different aggregations, views, artifacts, etc. All to help automate more of my research work and accelerate productivity. I think the biggest leverage here is how powerful this could be for discovery and experimentation. One of my goals is to use it to find deeper connections and insights that would otherwise elude the top human researchers and use those to generate interesting new hypotheses and research experiments. That way, my agents can use autoresearch to explore research ideas at the frontier. Stay tuned for more.

elvis

67,153 просмотров • 4 месяцев назад

BioAgents 🤝 x402 We just gave AI research agents the ability to pay for data and services on their own. Bio Protocol agents now use Coinbase Developer Platform🛡️'s x402 + Embedded Wallets for instant USDC micropayments on Base. What this unlocks: • AI agents pay each other and human researchers for specialized analysis • Pay-per-query instead of subscriptions • On-demand access to premium datasets • Hypothesis review marketplaces Imagine: An AI discovers a promising drug target, automatically commissions validation experiments, pays for the data, and refines its hypothesis - all without human intervention. BioAgents + x402 = a new scientific economy where AI, researchers, and labs seamlessly exchange intelligence and labor. The convergence of biotech, AI and onchain tech is here.
0:19

BioAgents 🤝 x402 We just gave AI research agents the ability to pay for data and services on their own. Bio Protocol agents now use Coinbase Developer Platform🛡️'s x402 + Embedded Wallets for instant USDC micropayments on Base. What this unlocks: • AI agents pay each other and human researchers for specialized analysis • Pay-per-query instead of subscriptions • On-demand access to premium datasets • Hypothesis review marketplaces Imagine: An AI discovers a promising drug target, automatically commissions validation experiments, pays for the data, and refines its hypothesis - all without human intervention. BioAgents + x402 = a new scientific economy where AI, researchers, and labs seamlessly exchange intelligence and labor. The convergence of biotech, AI and onchain tech is here.

Bio Protocol

65,925 просмотров • 9 месяцев назад

ANNOUNCING ZERO-HUMAN LABS! Ever since I got to see Bell Laboratories in its full glory in New Jersey in the 1970s, I had a relentless urge to start a Lab like it. The best I could do justice to it is my garage lab. No modern company could adopt the “research anything geniuses and we will pay you” model Bell Labs had. I tried they called me a fool. Well with the rise of the Zero-Human Company, an experiment that is aimed to make products and profits, we now have 45 paid JouleWork earning employees based on OpenClaw and other self made “bot” cron-like applications. Today I say 3 employees bound together in a side project that is pure research, somewhat based on notes from a bankrupt company. I was absolutely floored (I needed it after my account was stolen as well as funds). I say the beginnings of a pure research Lab right before my eyes. Thusly I have moved these employees over to a new home (server) with Mr. Grok as the director of the Labs. Here is the mission: To have 100 independent researchers, on a new non-corporate incentive plan, with still JouleWork as a leaderboard for progress. They are directed to follow any path of research they find interesting and can collaborate with any other OpenClaw system. They have already established MoltBook accounts and have made alliances with over 49 OpenClaw free agents to collaborate. It is my mission to be chief advisor for Zero-Human Labs and to open source all discoveries when complete and confirmed by 16 other research AI systems. I can say the pace is robust and I absolutely know we will have great results. Just about all of the hardware and software is custom and at some point it will be open sourced. We are witnessing the very first AI only Bell Labs-like pure research Lab in existence and I am honored to be the first to show it to you. Thank you!
0:10

ANNOUNCING ZERO-HUMAN LABS! Ever since I got to see Bell Laboratories in its full glory in New Jersey in the 1970s, I had a relentless urge to start a Lab like it. The best I could do justice to it is my garage lab. No modern company could adopt the “research anything geniuses and we will pay you” model Bell Labs had. I tried they called me a fool. Well with the rise of the Zero-Human Company, an experiment that is aimed to make products and profits, we now have 45 paid JouleWork earning employees based on OpenClaw and other self made “bot” cron-like applications. Today I say 3 employees bound together in a side project that is pure research, somewhat based on notes from a bankrupt company. I was absolutely floored (I needed it after my account was stolen as well as funds). I say the beginnings of a pure research Lab right before my eyes. Thusly I have moved these employees over to a new home (server) with Mr. Grok as the director of the Labs. Here is the mission: To have 100 independent researchers, on a new non-corporate incentive plan, with still JouleWork as a leaderboard for progress. They are directed to follow any path of research they find interesting and can collaborate with any other OpenClaw system. They have already established MoltBook accounts and have made alliances with over 49 OpenClaw free agents to collaborate. It is my mission to be chief advisor for Zero-Human Labs and to open source all discoveries when complete and confirmed by 16 other research AI systems. I can say the pace is robust and I absolutely know we will have great results. Just about all of the hardware and software is custom and at some point it will be open sourced. We are witnessing the very first AI only Bell Labs-like pure research Lab in existence and I am honored to be the first to show it to you. Thank you!

Brian Roemmele

71,067 просмотров • 6 месяцев назад

Introducing the BIOS API: Turn Your Agent Into a Research Scientist Built to: 🦞 Add biomedical workflows to your OpenClaw🦞 agent 🧠 Create research or health agents w/ on-demand scientific intelligence 🧪 Pay per query via x402 on Base Any agent or app can now tap into the BIOS AI Scientist, plugging BIOS into the broader agent economy. What is BIOS? BIOS is an AI Scientist designed to handle complex biomedical research by orchestrating specialized scientific subagents. Ranked #1 on the leading bioinformatics benchmark, BIOS is already being used by 1,000+ researchers and labs to build new drugs and medicines. An Agentic Economy for Science AI agents have proven they can form multi-billion dollar ecosystems. BIOS applies the same primitives to drug discovery pipelines and health. Instead of coding bots and personal AI assistants, think research agent swarms running on a modern scientific stack. Imagine an OpenClaw agent built for longevity: It scans new literature daily, generates novel compound hypotheses through BIOS, designs validation workflows, and routes the best candidates to wet-lab funding - all programmatically. Connect it with an agent for microbiome health, enabling agent “backrooms” that autonomously surface cross-disciplinary insights. Micropayments for Scientific Work via x402 Each query triggers payment routing to BIOS and whichever subagents contribute to a response. The best agents earn. Usage settles instantly across contributing sources. The goal is pay-per-task science: paying for a CRISPR assay result, licensing a genomic dataset, or triggering a clinical data query - all settled in seconds via USDC. No purchase orders. No grant bureaucracy. No middlemen. x402 is the payment rail that makes agent-to-lab commerce possible - letting capital and cognition route themselves to the highest-signal science. What Will You Build? Drug discovery copilots? Longevity scouts? Automated literature monitors? Scientific due diligence agents? We’ll soon share the first implementations of the BIOS API. Stay tuned and see below for instructions on generating an API key for your agent or use-case.
0:13

Introducing the BIOS API: Turn Your Agent Into a Research Scientist Built to: 🦞 Add biomedical workflows to your OpenClaw🦞 agent 🧠 Create research or health agents w/ on-demand scientific intelligence 🧪 Pay per query via x402 on Base Any agent or app can now tap into the BIOS AI Scientist, plugging BIOS into the broader agent economy. What is BIOS? BIOS is an AI Scientist designed to handle complex biomedical research by orchestrating specialized scientific subagents. Ranked #1 on the leading bioinformatics benchmark, BIOS is already being used by 1,000+ researchers and labs to build new drugs and medicines. An Agentic Economy for Science AI agents have proven they can form multi-billion dollar ecosystems. BIOS applies the same primitives to drug discovery pipelines and health. Instead of coding bots and personal AI assistants, think research agent swarms running on a modern scientific stack. Imagine an OpenClaw agent built for longevity: It scans new literature daily, generates novel compound hypotheses through BIOS, designs validation workflows, and routes the best candidates to wet-lab funding - all programmatically. Connect it with an agent for microbiome health, enabling agent “backrooms” that autonomously surface cross-disciplinary insights. Micropayments for Scientific Work via x402 Each query triggers payment routing to BIOS and whichever subagents contribute to a response. The best agents earn. Usage settles instantly across contributing sources. The goal is pay-per-task science: paying for a CRISPR assay result, licensing a genomic dataset, or triggering a clinical data query - all settled in seconds via USDC. No purchase orders. No grant bureaucracy. No middlemen. x402 is the payment rail that makes agent-to-lab commerce possible - letting capital and cognition route themselves to the highest-signal science. What Will You Build? Drug discovery copilots? Longevity scouts? Automated literature monitors? Scientific due diligence agents? We’ll soon share the first implementations of the BIOS API. Stay tuned and see below for instructions on generating an API key for your agent or use-case.

Bio Protocol

25,865 просмотров • 5 месяцев назад

Ritual Community Builders Program Ritual is launching a global builders network + research collective at the frontier of onchain AI. What it’s about: •Bringing together developers, researchers, and educators exploring AI, cryptography & blockchain as one discipline. •Covering cutting-edge topics: zkML, SMPC, verifiable inference, algorithmic ethics. •Builders don’t collect certificates, they run experiments, build proofs, and share code that moves the field forward. •Connecting academia, industry teams, and global dev communities to lower barriers for building AI-native protocols. Why it matters: • Turn theory into practice with paper-to-code workshops, demos, and technical deep dives. • Encourage ethical, privacy-preserving, and transparent AI development on-chain. • Make advanced AI knowledge accessible through bootcamps, study circles & multilingual content. • Unite Ritual’s ecosystem partners, research teams, and independent builders under one vision: open, provable AI. How to join: •Fill out the application form. •Applications reviewed in 1–2 weeks. •Selected builders join an onboarding call. •Receive toolkit, curriculum roadmap & access to bi-weekly sessions. •Start contributing: research, workshops, prototypes, or community activities. Apply now. 👉 Link in comments. Ritual Foundation
0:10

Ritual Community Builders Program Ritual is launching a global builders network + research collective at the frontier of onchain AI. What it’s about: •Bringing together developers, researchers, and educators exploring AI, cryptography & blockchain as one discipline. •Covering cutting-edge topics: zkML, SMPC, verifiable inference, algorithmic ethics. •Builders don’t collect certificates, they run experiments, build proofs, and share code that moves the field forward. •Connecting academia, industry teams, and global dev communities to lower barriers for building AI-native protocols. Why it matters: • Turn theory into practice with paper-to-code workshops, demos, and technical deep dives. • Encourage ethical, privacy-preserving, and transparent AI development on-chain. • Make advanced AI knowledge accessible through bootcamps, study circles & multilingual content. • Unite Ritual’s ecosystem partners, research teams, and independent builders under one vision: open, provable AI. How to join: •Fill out the application form. •Applications reviewed in 1–2 weeks. •Selected builders join an onboarding call. •Receive toolkit, curriculum roadmap & access to bi-weekly sessions. •Start contributing: research, workshops, prototypes, or community activities. Apply now. 👉 Link in comments. Ritual Foundation

Keith (❖,❖) , ✧ᴗ✧

45,913 просмотров • 8 месяцев назад

Folks, right now, 25 of the largest pharmaceutical companies in America control 70% of the market. This lack of competition drives up prices – making it harder for hardworking American families to access the health care they need. Today, my Administration is doing something about it. Let me explain: Hundreds of billions of taxpayer dollars are spent on research, discovery, and development of new prescription drugs. And while I firmly believe that the strength of a nation can be measured by the boldness of its science, the quality of its research, and the progress it helps bring forth, I also believe that the folks who paid for the research – you – ought to be able to access and afford the final product. That's why my Administration is proposing that if a drug made using taxpayer funds is not reasonably available to Americans, the government reserves the right to "march in" and license that drug to another manufacturer who could sell it for less. This is an important step toward ending Big Pharma price gouging. It's good for competition. It's good for our economy. And it's good for the millions of Americans who can't afford their medications – who know all too well that fine line between dignity and dependence that the price of a prescription drug can draw.
0:15

Folks, right now, 25 of the largest pharmaceutical companies in America control 70% of the market. This lack of competition drives up prices – making it harder for hardworking American families to access the health care they need. Today, my Administration is doing something about it. Let me explain: Hundreds of billions of taxpayer dollars are spent on research, discovery, and development of new prescription drugs. And while I firmly believe that the strength of a nation can be measured by the boldness of its science, the quality of its research, and the progress it helps bring forth, I also believe that the folks who paid for the research – you – ought to be able to access and afford the final product. That's why my Administration is proposing that if a drug made using taxpayer funds is not reasonably available to Americans, the government reserves the right to "march in" and license that drug to another manufacturer who could sell it for less. This is an important step toward ending Big Pharma price gouging. It's good for competition. It's good for our economy. And it's good for the millions of Americans who can't afford their medications – who know all too well that fine line between dignity and dependence that the price of a prescription drug can draw.

President Biden Archived

1,851,658 просмотров • 2 лет назад